Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
SciSparc's NeuroThera Labs Secures Conditional TSX Approval to Acquire 54% Stake in CliniQuantum
NeuroThera Labs receives conditional TSX approval to acquire 54% of quantum simulation analytics firm CliniQuantum for ~$9.46M in shares.
Pharma Now Editorial Team
FDA Finalizes Bioequivalence Statistical Guidance, Replacing 2001 Framework for NDA and ANDA Sponsors
FDA finalizes updated bioequivalence statistical guidance, replacing the 2001 framework. NDA and ANDA sponsors must reconcile BE protocols and submission packages.
Pharma Now Editorial Team
Quotient Sciences Advances AI-Designed Oral Formulation into Phase I Following MHRA Approval
Quotient Sciences doses Phase I subjects with an AI-designed oral formulation after MHRA approval, marking a regulatory milestone for computational drug product development.
Pharma Now Editorial Team
Anaveon Achieves Phase 1 Clinical Benefit Signal for ANV600 as Company Seeks Oncology Partners
Anaveon presents EXPAND-1 Phase 1 data for ANV600 at ASCO 2026, reporting 42% disease control in monotherapy, as the company seeks global oncology partners.
Pharma Now Editorial Team
